Safety and Efficacy of Oral PTK787 in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)

Clinical trial NCT00138632 · COMPLETED

Trial details

NCT number: NCT00138632
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Wet Age-Related Macular Degeneration

Start date: 2005-09-01
Primary completion: 2007-11-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.